aRCC: 1L Treatment Options and Patient Management

 

aRCC: 1L Treatment Options and Patient Management
12:14

ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Update on CheckMate 214 With Extended 5-Year Follow-Up: Efficacy and Safety of Nivo+Ipi vs. Sunitinib for 1L Treatment of Advanced sRCC

FEATURING Scott Tykodi
  • 173 views
  • March 14, 2022
08:40

Thomas Hutson

Overview of CheckMate 214: 5-Year Data on Nivo+Ipi in Patients With Advanced RCC

  • 92 views
  • November 30, 2021
16:00

ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Germline Mutations of Interests in Renal Cell Carcinoma

FEATURING Michael Dean
  • 177 views
  • February 26, 2022
  • 1
09:23

ASCO Genitourinary Cancers Symposium

ASCO GU 2022 on Molecular Alterations Across Sites of Metastasis in Patients With RCC: Abstract 287 Updates

FEATURING Rana McKay
  • 69 views
  • February 24, 2022
16:34

ASCO Genitourinary Cancers Symposium

ASCO GU 2022 Highlights on Adjuvant and Consolidative Therapy in Oligometastatic Renal Cell Carcinoma

FEATURING Naomi Haas
  • 134 views
  • February 24, 2022
06:04

ASCO 2022 Conference Coverage

ASCO 2022 on Safety & Clinical Activity of MEDI5752, a PD-1/CTLA-4 Bispecific Checkpoint Inhibitor, as Monotherapy With Advanced RCC: Preliminary Results From the FTIH Trial

FEATURING Laurence Albiges
  • 130 views
  • June 30, 2022
47:32

Moffitt Cancer Center

Mechanisms of Resistance and Toxicity to Immune Checkpoint Therapy in Genitourinary Malignancies

FEATURING Jianjun Gao
  • 238 views
  • August 25, 2022
13:28

Total Health

2022 ASCO Renal Cell Carcinoma Updates

FEATURING Manojkumar Bupathi
  • 187 views
  • August 31, 2022
12:53

O'Neal Comprehensive Cancer Center at UAB

Dual Immunotherapy in RCC

FEATURING Arnab Basu
  • 539 views
  • September 16, 2022
  • 5
20:47

ecancer

ESMO 2022 on the Latest in mRCC

FEATURING Javier Puente, Bernard Escudier, Viktor Grünwald, Stéphane Oudard
  • 186 views
  • September 30, 2022
  • 1
21:09

Mário Fontes-Sousa

Evolving Landscape of 1L Systemic Treatment in Metastatic Renal Cell Carcinoma

  • 214 views
  • October 21, 2022
20:23

Aly-Khan A. Lalani

Choosing Wisely: 1L Combination Treatment for Advanced RCC

  • 737 views
  • December 6, 2022
  • 4
06:50

ecancer

ESMO 2022 Updates in Renal Cancer

FEATURING Toni Choueiri
  • 283 views
  • September 30, 2022
19:41

Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

  • 1,878 views
  • December 13, 2022
  • 10
10:55

Yale Cancer Center

Systemic Therapies for Clear Cell RCC: Where Are We Now?

FEATURING David Braun
  • 459 views
  • December 23, 2022
  • 2
14:14

PrecisCa

GU Tumor Board: 61 y/o Male With mRCC With Disease Progression After Multiple Lines of Systemic Therapy

FEATURING Matthew Rettig, Susan Slovin, Tyler Fraum, Jason Abel, Pretesh Patel
  • 197 views
  • December 28, 2022
  • 1